Summary
Nifedipine (10 mg) was administered orally to 8 normotensive volunteers. Various measurements such as concentration in serum, blood pressure, and heart rate, were made at 0, 20′, 40′, I, 2, 3, 4, 6, 8 and 24 h after administration.
The sample serum, internal standard (diethyl 2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate), HCl and NaN02 were allowed to react and GLC-ECD was carried out after extration with organic solvent. The retention time was 3 min for nifedipine and 4 min for internal standard.
Absorption curves were classified into 3 types: a rapid absorption rate (2 subjects) in which the maximum measured nifedipine concentration (70–80 ng/ml) was obtained, within 20–40 min after administration, a slower absorption rate (3 subjects) and an intermediate absorption rate (3 subjects) and an intermediate absorption rate (3 subjects). A decrease in systolic blood pressure was observed, but no significant difference in diastolic blood pressure and heart rate could be noted among the volunteers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bossert F. und Vater W., (1971): Dihydropyrine, eine neue Gruppe stark wirksamer Coronartherapeutika. Naturwissenshaften,58. 578.
Vater W., Kroneberg G., Hoffmeister F. Kaller H., Meng K., Oberdorf A., Puis W., Schlolßmann K. and Stoepel K., (1972): Pharmacology of 4-(2′ -Ni trophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethylester (Nifedipine). Arzeim. Forsch.,22. 1–14.
Hashimoto K., Taira N., Ono H., Chiba S., Hashimoto K., Endoh M., Kokubun H., Iijima T., Kimura T., Kubota K. and Ogura K., Nifedipine (1975), Basis of its pharmacological effect. In 1st International Nifedipine (Adalat) Symposium. Hashimoto, Kimura and Kobayashi (Eds). pp 11–22, University of Tokyo Press, Tokyo.
Berson J. A. and Brown E., (1955): Studies on dihydropyridines. I, The preparation of unsymmetrical 4-aryll,4-dihydropyridines by the Hantzsch-Beyer synthesis. J. Am. Chern. Soc.,77. 444–447.
Hantzsch A., (1882): Ueber die Synthese pyridinartiger Verbindungen aus Acetessigather und Aldehydammoniak. Justus Liebigi’s Annalen der Chemie,215. 1–82.
Schlolßmann K., (1972): Fluorometrische bestimmung des 4-(2’ -nitrophenyl)-2,6-dimethyl-1,4-dihydropridin3,5-dicarbonsauredimethylester und seines hauptmetaboliten. Arzneim. Forsch.,22. 60–62. ßολιτεν Aρζνειμ Φορσωη.22. 60–62.
Pedersen O. L. and Mikkelsen E., (1971): Acute and chronic effects of nifedipine in arterial hypertension. Eur. J. Pharmacol.,14. 375–381.
Pedersen O. L., Christensen N. J. and Ramsch K., (1980): Comparison of acute effects of nifedipine in normotensive and hypertensive man. J. Cardiovasc. Pharmacol.,2, 357–366.
Duhm B., Maul W., Medenwald H., Patzschke K. und Wegner L. A., (1972): Tierexperimentelle untersuchungen zur pharmakokinetik und biotransformation von radioaktive markiertem 4-(2′ -nitrophenyl)-2,6dimethyl-I,4-dihydropyridin-3,5-dicarbonsäuredimethylester. Arzneim. Forsch.,22. 42–52.
Medenwald H., SchloBmann K. und Wiinsche C., (1972): Strukturaufklaung der renalen ausscheidungsprodukte von 4-(2′ -nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsauredimethylester. Armeim. Forsch.,22. 53–56.
Hoster F.A., Duhm B., Maul W., Mendenwald H., Patzschke K. und Wegner L. A., (1972): Klinische Untersuchungen zur Phamakokinetik von radioaktive markiertem 4-(2′ -ntophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsauredimethylester. Arzneim. Forsch.,22. 330–334.
Higuchi S., Sasaki H. and Sado T., (1975): Determination of a new cerebral vasodilator 2,6-dimethyl-4-(3nitrophenyl)-I,4-dihydropyridine-3,5-dicarboxylic acid 3-2-(N-benzyl-N-methylamino)-ethyl ester 5-methyl ester hydrochloride (YC-93) in plasma by electron capture gas chromatography. J. Chromatogr.,110. 301–307.
Higuchi S. and Shiobara Y., (1978): Quantitative determination of nifedipine in human plasma by selected ion monitoring. Biomed. Mass Spectrom.,5. 220–223.
Jakobsen P., Pedersen O.L. and Mikkelsen E., (1979): Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection J. Chromatogr.,162. 81–87.
Kondo S., Kuchiki A., Yamamoto K., Akimoto K., Takanashi K., Awata N. and Sugimoto I., (1980): Identification of nifedipine metabolites and their determination by gas chromatography. Chern. Pharm. Bull. (Tokyo),28. 1–7.
Wagner J. G. and Nelson E., (1963): Per cent absorbed time plots derived from blood level and/or urinary excretion data. J. Pharm. Sci.,52. 1056–1062.
Olivari M.T., Bertorelli C., Polese A., Fiorentini C., Moruzzi P. and Guazzi M. D., (1979): Treatment of hypertention with nifedipine, a calcium antagonistic agent. Circulation59. 1056–1062.
Thibonnier M., Bonnet F. and Corvol P., (1980): Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension. Eur. J. Clin. Pharmacol.,17. 161–164.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakashima, T., Inoki, M. & Nakanishi, Y. Nefedipine Serum Concentration; Effects upon blood pressure and heart rate in normotensive volunteers. European Journal of Drug Metabolism and Pharmacokinetics 9, 73–78 (1984). https://doi.org/10.1007/BF03189607
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189607